SCHEMBL19862962

SCHEMBL19862962

c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccc(-c5ccc(-c6cc7c8ccccc8oc7c7c8ccccc8n(-c8ccccc8)c67)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
BRCA1 P38398 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 2/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PPARG P37231 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
ALOX5 P09917 1/20 0.31
LMNA P02545 1/20 0.30
CDC14B O60729 1/20 0.30
CDC14A Q9UNH5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862941 1.00 ALDH1A1 (0.35) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862934 1.00 ALDH1A1 (0.35) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862933 0.99 ALDH1A1 (0.35) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862960 0.99 ALDH1A1 (0.35) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862944 0.99 ALDH1A1 (0.35) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862847 0.98 MEN1 (0.33) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862835 0.98 MEN1 (0.33) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL18594359 0.98 MEN1 (0.33) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862930 0.98 ALDH1A1 (0.36) ALDH1A1POLBMEN1TSHRBRCA1
SCHEMBL19862856 0.97 ALDH1A1 (0.33) ALDH1A1POLBMEN1TSHRBRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 ALDH1A1 242/4885POLB 3598/4885MEN1 798/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 ALDH1A1 242/4885POLB 3598/4885MEN1 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.